Virtus ETF Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Virtus ETF Advisers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$832K	Sell	13,715 -402	-3%	-$23.4K	0.39%	53
2025 Q4	$761K	Buy	14,117 +1,767	+14%	+$85K	0.36%	64
2025 Q3	$557K	Buy	+12,350	New	+$577K	0.31%	90
2023 Q3	–	Sell	-11,124	Closed	-$711K	–	440
2023 Q2	$711K	Sell	11,124 -989	-8%	-$66.3K	0.42%	108
2023 Q1	$840K	Buy	12,113 +1,412	+13%	+$99.6K	0.46%	87
2022 Q4	$770K	Buy	10,701 +1,399	+15%	+$105K	0.4%	92
2022 Q3	$661K	Sell	9,302 -402	-4%	-$29.2K	0.26%	132
2022 Q2	$747K	Buy	+9,704	New	+$739K	0.28%	98
2020 Q3	–	Sell	-1,142	Closed	-$67K	–	336
2020 Q2	$67K	Buy	1,142 +725	+174%	+$43.4K	0.03%	334
2020 Q1	$23K	Sell	417 -502	-55%	-$30.7K	0.01%	323
2019 Q4	$59K	Buy	+919	New	+$52.6K	0.01%	296

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtus ETF Advisers's BMY Position: Q1 2026 in Review

Virtus ETF Advisers reduced its Bristol-Myers Squibb (BMY) stake by 2.8% in Q1 2026, selling an estimated $23.4K and leaving 13,715 shares worth $832K. The position accounts for 0.39% of the portfolio, ranked #53.

Virtus ETF Advisers first reported a position in BMY in Q4 2019 and has held it in 11 quarters since. The position peaked at $840K in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Virtus ETF Advisers held 13,715 shares of Bristol-Myers Squibb worth $832K as of Q1 2026.
Virtus ETF Advisers sold 402 Bristol-Myers Squibb shares in Q1 2026, an estimated $23.4K.
Bristol-Myers Squibb made up 0.39% of Virtus ETF Advisers's portfolio in Q1 2026, its #53 holding.
Virtus ETF Advisers first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 11 quarters since.
Virtus ETF Advisers's Bristol-Myers Squibb position peaked at $840K in Q1 2023.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Virtus ETF Advisers's 13F filing for Q1 2026, filed 14 May 2026.